Guidelines for radioiodine therapy of differentiated thyroid cancer

被引:0
|
作者
M. Luster
S. E. Clarke
M. Dietlein
M. Lassmann
P. Lind
W. J. G. Oyen
J. Tennvall
E. Bombardieri
机构
[1] University of Würzburg,Department of Nuclear Medicine
[2] Guys and St. Thomas Hospital,Department of Nuclear Medicine
[3] University of Cologne,Department of Nuclear Medicine and Endocrinology
[4] Positron Emission Tomography/Computed Tomography Centre,Department of Oncology
[5] Radboud University Nijmegen Medical Centre,undefined
[6] Lund University Hospital,undefined
[7] National Cancer Institute Foundation,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词
Radioiodine therapy; Thyroid remnant ablation; Radioiodine treatment; Guidelines;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Faecalibacterium prausnitzii in Differentiated Thyroid Cancer Patients Treated with Radioiodine
    Fernandes, Ana
    Oliveira, Ana
    Carvalho, Ana Luisa
    Soares, Raquel
    Barata, Pedro
    NUTRIENTS, 2023, 15 (12)
  • [32] Treatment of advanced differentiated thyroid carcinoma with high activity radioiodine therapy
    Haq, MS
    McCready, RV
    Harmer, CL
    NUCLEAR MEDICINE COMMUNICATIONS, 2004, 25 (08) : 799 - 805
  • [33] Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
    Mikalsen, Lars Tore Gyland
    Arnesen, Marius Rothe
    Bogsrud, Trond Velde
    Dale, Einar
    Stokke, Caroline
    ACTA ONCOLOGICA, 2017, 56 (06) : 894 - 897
  • [34] Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation
    Musso, Laura
    Maltese, Cristina
    Beretta, Giulio
    Patelli, Ilaria
    Raffa, Stefano
    Piccardo, Arnoldo
    Fiz, Francesco
    Vera, Lara
    Albertelli, Manuela
    Minuto, Michele
    Ferone, Diego
    Bagnasco, Marcello
    Gay, Stefano
    PHARMACEUTICALS, 2025, 18 (04)
  • [35] Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study
    Hong, Chae Moon
    Shin, Ji-Yeon
    Kim, Byeong Il
    Song, Ho-Chun
    Yoon, Joon-Kee
    Won, Kyoung Sook
    Kim, Seong-Min
    Cho, Ihn Ho
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (05) : 1661 - 1670
  • [36] Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
    Esquerré-Lamare C.
    Isus F.
    Moinard N.
    Bujan L.
    Basic and Clinical Andrology, 2015, 25 (1)
  • [37] Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany
    Hoelzer, S
    Steiner, D
    Bauer, R
    Reiners, C
    Farahati, J
    Hundahl, SA
    Dudeck, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (10) : 1465 - 1472
  • [38] Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer
    Albano, Domenico
    Bertagna, Francesco
    Panarotto, Maria Beatrice
    Giubbini, Raffaele
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [40] Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review
    Bima Indra
    Nur Qodir
    Didit Pramudhito
    Legiran Legiran
    Zen Hafy
    Andi M Iqbal Yusran
    Journal of the Egyptian National Cancer Institute, 37 (1)